How Mycobacterium tuberculosis goes to sleep: The dormancy survival regulator DosR a decade later

Future Microbiology

Volumn 7, Issue 4, 2012, Pages 513-518

  Boon, Calvin ^a   Dick, Thomas ^b  

^a Woodlands Central Industrial Estate   (Singapore)

^b NONE

Author keywords

dormancy; latency; Mycobacterium tuberculosis; nontuberculous mycobacteria; persistence

Indexed keywords

BEDAQUILINE; METRONIDAZOLE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DORMANCY SURVIVAL REGULATOR; UNCLASSIFIED DRUG;

ATYPICAL MYCOBACTERIUM; BACTERIAL INFECTION; DORMANCY; GENE EXPRESSION; GRANULOMA; HUMAN; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SPUTUM CULTURE; SURVIVAL; TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICROBIAL VIABILITY; MYCOBACTERIUM TUBERCULOSIS; PROTEIN KINASES; TUBERCULOSIS;

BACILLUS (BACTERIUM); BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 84858955831     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.14     Document Type: Review

References (64)

1. Fujita M, Losick R. Evidence that entry into sporulation in Bacillus subtilis is governed by a gradual increase in the level and activity of the master regulator Spo0A. Genes Dev. 19(18), 2236-2244 (2005).
2. Traag BA, Driks A, Stragier P et al. Do mycobacteria produce endospores? Proc. Natl Acad. Sci. USA 107(2), 878-881 (2010).
3. Boon C, Dick T. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J. Bacteriol. 184(24), 6760-6767 (2002). Describes the discovery of DosR and its essential role in dormancy survival of Mycobacterium bovis BCG.
4. Wayne LG, Sohaskey CD. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55, 139-163 (2001). Gives a comprehensive overview of hypoxic dormancy in M. tuberculosis before interest in the field suddenly grew.
5. Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64(6), 2062-2069 (1996). Describes Wayne's hypoxia-dormancy culture model.
6. Barry CE 3rd, Boshoff HI, Dartois V et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7(12), 845-855 (2009).
7. Chao MC, Rubin EJ. Letting sleeping Dos lie: does dormancy play a role in tuberculosis? Annu. Rev. Microbiol. 64, 293-311 (2010). Gives a comprehensive overview of the current state of research on various dormancies in M. tuberculosis.
8. Dick T. Dormant tubercle bacilli: the key to more effective TB chemotherapy? J. Antimicrob. Chemother. 47(1), 117-118 (2001).
9. Lim A, Eleuterio M, Hutter B, Murugasu-Oei B, Dick T. Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. J. Bacteriol. 181(7), 2252-2256 (1999).
10. Boon C, Li R, Qi R, Dick T. Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J. Bacteriol. 183(8), 2672-2676 (2001).
11. Via LE, Lin PL, Ray SM et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76(6), 2333-2340 (2008). Shows hypoxia and metronidazole activity in a rabbit model of TB.
12. Lenaerts AJ, Hoff D, Aly S et al. Location of persisting mycobacteria in a guinea pig model of tuberculosis revealed by r207910. Antimicrob. Agents Chemother. 51(9), 3338-3345 (2007).
13. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685), 537-544 (1998).
14. Dasgupta N, Kapur V, Singh KK et al. Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis. Tuber. Lung Dis. 80(3), 141-159 (2000).
15. Schnappinger D, Ehrt S, Voskuil MI et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198(5), 693-704 (2003).
16. Park HD, Guinn KM, Harrell MI et al. Rv3133c/DosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 48(3), 833-843 (2003).
17. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc. Natl Acad. Sci. USA 98(13), 7534-7539 (2001).
18. Voskuil MI, Schnappinger D, Visconti KC et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198(5), 705-713 (2003).
19. Kumar A, Deshane JS, Crossman DK et al. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J. Biol. Chem. 283(26), 18032-18039 (2008).
20. Shiloh MU, Manzanillo P, Cox JS. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 3(5), 323-330 (2008).
21. Honaker RW, Dhiman RK, Narayanasamy P, Crick DC, Voskuil MI. DosS responds to a reduced electron transport system to induce the Mycobacterium tuberculosis DosR regulon. J. Bacteriol. 192(24), 6447-6455 (2010).
22. Honaker RW, Leistikow RL, Bartek IL, Voskuil MI. Unique roles of DosT and DosS in DosR regulon induction and Mycobacterium tuberculosis dormancy. Infect. Immun. 77(8), 3258-3263 (2009).
23. Kumar A, Toledo JC, Patel RP, Lancaster JR Jr, Steyn AJ. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc. Natl Acad. Sci. USA 104(28), 11568-11573 (2007).
24. Roberts DM, Liao RP, Wisedchaisri G, Hol WG, Sherman DR. Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J. Biol. Chem. 279(22), 23082-23087 (2004).
25. Chao JD, Papavinasasundaram KG, Zheng X et al. Convergence of Ser/Thr and two-component signaling to coordinate expression of the dormancy regulon in Mycobacterium tuberculosis. J. Biol. Chem. 285(38), 29239-29246 (2010).
26. Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog. 7(6), E1002093 (2011).
27. Low KL, Shui G, Natter K et al. Lipid droplet-associated proteins are involved in the biosynthesis and hydrolysis of triacylglycerol in Mycobacterium bovis bacillus Calmette-Guerin. J. Biol. Chem. 285(28), 21662-21670 (2010).
28. Lazebnik Y. Can a biologist fix a radio? - Or, what I learned while studying apoptosis. Cancer Cell 2(3), 179-182 (2002).
29. Arnvig KB, Comas I, Thomson NR et al. Sequence-based analysis uncovers an abundance of non-coding RNA in the total transcriptome of Mycobacterium tuberculosis. PLoS Pathog. 7(11), E1002342 (2011).
30. Leistikow RL, Morton RA, Bartek IL, Frimpong I, Wagner K, Voskuil MI. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J. Bacteriol. 192(6), 1662-1670 (2010). Confirms the essential role of DosR in dormancy survival of M. tuberculosis.
31. Rao SP, Alonso S, Rand L, Dick T, Pethe K. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 105(33), 11945-11950 (2008).
32. Tan MP, Sequeira P, Lin WW et al. Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses. PLoS ONE 5(10), E13356 (2010).
33. Diacon AH, Pym A, Grobusch M et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N. Engl. J. Med. 360(23), 2397-2405 (2009). Describes the dramatic efficacy of a new drug candidate that has dual activity against growing and hypoxic-dormant bacilli in vitro.
34. Andries K, Verhasselt P, Guillemont J et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307(5707), 223-227 (2005).
35. Gengenbacher M, Rao SP, Pethe K, Dick T. Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology 156(Pt 1), 81-87 (2010).
36. Watanabe S, Zimmermann M, Goodwin MB, Sauer U, Barry CE 3rd, Boshoff HI. Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis. PLoS Pathog. 7(10), E1002287 (2011).
37. Drumm JE, Mi K, Bilder P et al. Mycobacterium tuberculosis universal stress protein Rv2623 regulates bacillary growth by ATP-binding: requirement for establishing chronic persistent infection.PLoS Pathog. 5(5), E1000460 (2009).
38. Hu Y, Movahedzadeh F, Stoker NG, Coates AR. Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo. Infect. Immun. 74(2), 861-868 (2006).
39. Bashir N, Kounsar F, Mukhopadhyay S, Hasnain SE. Mycobacterium tuberculosis conserved hypothetical protein rRv2626c modulates macrophage effector functions. Immunology 130(1), 34-45 (2010).
40. Sharma D, Bose A, Shakila H, Das TK, Tyagi JS, Ramanathan VD. Expression of mycobacterial cell division protein, FtsZ, and dormancy proteins, DevR and Acr, within lung granulomas throughout guinea pig infection. FEMS Immunol. Med. Microbiol. 48(3), 329-336 (2006).
41. Black GF, Thiel BA, Ota MO et al. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin. Vaccine Immunol. 16(8), 1203-1212 (2009).
42. Commandeur S, Lin MY, Van Meijgaarden KE et al. Double- and monofunctional CD4 and CD8 T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals. Eur. J. Immunol. 41(10), 2925-2936 (2011).
43. Schuck SD, Mueller H, Kunitz F et al. Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection. PLoS ONE 4(5), E5590 (2009).
44. Leyten EM, Lin MY, Franken KL et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 8(8), 2052-2060 (2006).
45. Garton NJ, Waddell SJ, Sherratt AL et al. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 5(4), E75 (2008).
46. Parish T, Smith DA, Kendall S, Casali N, Bancroft GJ, Stoker NG. Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect. Immun. 71(3), 1134-1140 (2003).
47. Bartek IL, Rutherford R, Gruppo V et al. The DosR regulon of M. tuberculosis and antibacterial tolerance. Tuberculosis (Edinb.) 89(4), 310-316 (2009).
48. Rustad TR, Harrell MI, Liao R, Sherman DR. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE 3(1), E1502 (2008).
49. Converse PJ, Karakousis PC, Klinkenberg LG et al. Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models. Infect. Immun. 77(3), 1230-1237 (2009).
50. Malhotra V, Sharma D, Ramanathan VD et al. Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis. FEMS Microbiol. Lett. 231(2), 237-245 (2004).
51. Lin PL, Rodgers M, Smith L et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77(10), 4631-4642 (2009).
52. Desai CR, Heera S, Patel A, Babrekar AB, Mahashur AA, Kamat SR. Role of metronidazole in improving response and specific drug sensitivity in advanced pulmonary tuberculosis. J. Assoc. Physicians India 37(11), 694-697 (1989).
53. Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175(4), 367-416 (2007).
54. Falkinham JO 3rd. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg. Infect. Dis. 17(3), 419-424 (2011).
55. Medjahed H, Gaillard JL, Reyrat JM. Mycobacterium abscessus: a new player in the mycobacterial field. Trends Microbiol. 18(3), 117-123 (2010).
56. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin. Infect. Dis. 52(5), 565-571 (2011).
57. Griffith DE. The talking Mycobacterium abscessus blues. Clin. Infect. Dis. 52(5), 572-574 (2011).
58. Gerasimova A, Kazakov AE, Arkin AP, Dubchak I, Gelfand MS. Comparative genomics of the dormancy regulons in mycobacteria. J. Bacteriol. 193(14), 3446-3452 (2011).
59. Lin MY, Reddy TB, Arend SM et al. Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria. Infect. Immun. 77(11), 5071-5079 (2009).
60. Dick T, Lee BH, Murugasu-Oei B. Oxygen depletion induced dormancy in Mycobacterium smegmatis. FEMS Microbiol. Lett. 163(2), 159-164 (1998).
61. O'Toole R, Smeulders MJ, Blokpoel MC, Kay EJ, Lougheed K, Williams HD. A two-component regulator of universal stress protein expression and adaptation to oxygen starvation in Mycobacterium smegmatis. J. Bacteriol. 185(5), 1543-1554 (2003).
62. Mayuri, Bagchi G, Das TK, Tyagi JS. Molecular analysis of the dormancy response in Mycobacterium smegmatis: expression analysis of genes encoding the DevR-DevS two-component system, Rv3134c and chaperone alpha-crystallin homologues. FEMS Microbiol. Lett. 211(2), 231-237 (2002).
63. Belenky P, Collins JJ. Microbiology. Antioxidant strategies to tolerate antibiotics.Science 334(6058), 915-916 (2011).
64. Metronidazole for Pulmonary Tuberculosis (South Korea). http://clinicaltrials.gov/ct2/show/NCT00425113